NUS produced these Guidelines in consultation with the Independent Clinical Research Contractors and the Association of the British Pharmaceutical Industry following the deaths of two students in the 1980s.

1. Student participation must be on a truly voluntary basis free from academic or financial pressure.

2. To ensure the above, no student should undertake experiments for ANY academic or researcher who tutors or lectures that student orwhois involved in their academic assessment.

3. To ensure the above, payments for participation in experiment should be standardised, in both NHS and private research at rates of payments which compensate the student for expenses and inconvenience. There should be no financial incentive to participate.

4. A national computerised register of those participating in all experiments should be kept which records incidents of side effect or ill health but which can also be used to identify individuals submitting themselves to a large number of experiments.

5. College authorities must monitor their own students' participation and tackle the unhealthy concentration of experiment participation among students involved in medical faculties and the associated natural sciences.

6. At any time a student should be able to free themselves from a previously agreed series of experiments.

7. Students should not sign documents which indemnify researchers against legal action. The NHS and private research companies should make their own insurance arrangements.

8. The scientific and medical authorities should indicate clearly the degree of risk involved. Obvious differences can be highlighted between the testing of totally new drugs and those which are already on the market but simply up for certification in the UK.